Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Pasut

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Joint Bone Spine|May 24, 2020
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in ItalyLuca Quartuccio, Francesca Valent, Enrico Pasut, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|May 19, 2021
Luca Quartuccio, Francesca Valent, Enrico Pasut, et al.
BMC Health Services Research|April 11, 2018
Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in ItalyNicola Lombardi, Li Wei, Maisoon Ghaleb, et al.
Viruses|July 27, 2022
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 OutbreakArianna Sonaglia, Rosanna Comoretto, Enrico Pasut, et al.
Global & Regional Health Technology Assessment|October 14, 2024
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian studyFiorenzo Santoleri, Paolo Abrate, Laura Pestrin, et al.
Immunotherapy|April 23, 2024
Adherence, persistence and treatment switching in psoriasisFiorenzo Santoleri, Felice Musicco, Chiara Fulgenzio, et al.
Current Medical Research and Opinion|November 23, 2023
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in ItalyFiorenzo Santoleri, Ruggero Lasala, Paolo Abrate, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Joint Bone Spine|May 24, 2020
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in ItalyLuca Quartuccio, Francesca Valent, Enrico Pasut, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|May 19, 2021
Luca Quartuccio, Francesca Valent, Enrico Pasut, et al.
BMC Health Services Research|April 11, 2018
Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in ItalyNicola Lombardi, Li Wei, Maisoon Ghaleb, et al.
Viruses|July 27, 2022
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 OutbreakArianna Sonaglia, Rosanna Comoretto, Enrico Pasut, et al.
Global & Regional Health Technology Assessment|October 14, 2024
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian studyFiorenzo Santoleri, Paolo Abrate, Laura Pestrin, et al.
Immunotherapy|April 23, 2024
Adherence, persistence and treatment switching in psoriasisFiorenzo Santoleri, Felice Musicco, Chiara Fulgenzio, et al.
Current Medical Research and Opinion|November 23, 2023
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in ItalyFiorenzo Santoleri, Ruggero Lasala, Paolo Abrate, et al.
Pageof 1